Literature DB >> 1803877

Extradural petrous bone and petroclival neoplasms.

L N Sekhar1, S Pomeranz, C N Sen.   

Abstract

Extradural petroclival tumours are composed of a spectrum of histological and anatomical configurations dictating a variety of surgical approaches. The experience with 68 such tumours operated at the University of Pittsburgh is presented, emphasizing the basal subfrontal and lateral approaches. 85% of these tumours are benign or low-grade malignancies, with 62% of these totally resected, resulting in a 5.4% recurrence rate. The operative mortality was 1.5% and major morbidity 3%. Well-planned surgery based on precise anatomical knowledge and imaging is the basis of treatment for petroclival tumours.

Entities:  

Mesh:

Year:  1991        PMID: 1803877     DOI: 10.1007/978-3-7091-9183-5_29

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  5 in total

1.  Dural and arachnoid membraneous protection of the abducens nerve at the petroclival region.

Authors:  M Faik Ozveren; Koichi Uchida; Ibrahim Tekdemir; Bengu Cobanoglu; Ismail Akdemir; Takeshi Kawase; Haluk Deda
Journal:  Skull Base       Date:  2002-11

2.  Dual-Port 2D and 3D Endoscopy: Expanding the Limits of the Endonasal Approaches to Midline Skull Base Lesions with Lateral Extension.

Authors:  Andre Beer-Furlan; Alexander I Evins; Luigi Rigante; Giulio Anichini; Philip E Stieg; Antonio Bernardo
Journal:  J Neurol Surg B Skull Base       Date:  2014-03-12

3.  Giant cranial base tumours.

Authors:  S Pomeranz; F Umansky; J Elidan; E Ashkenazi; A Valarezo; M Shalit
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 4.  Review of skull base surgery approaches: with special reference to pediatric patients.

Authors:  J D Kennedy; S J Haines
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Anatomical study on Meckel cave with endoscopic endonasal, endo-maxillary sinus, and endo-pterygoid process approaches.

Authors:  Xuejian Wang; Hao Yu; Zhenhua Cai; Zhifeng Wang; Baojun Ma; Yi Zhang; Zi Ye
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.